Oncotelic Therapeutics, Inc. ($OTLC) Insider Transactions

Last updated: 2026-03-14 11:46 UTC | Total transactions: 10

In the last 12 months, insiders at Oncotelic Therapeutics, Inc. ($OTLC) filed 10 transactions with the SEC: 8 open-market purchases totaling $29,332 and 0 sales totaling $0. Net insider sentiment: net buying.

Oncotelic Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).

Most Active Insiders

View all SEC Filings for Oncotelic Therapeutics, Inc. (OTLC).

Set Up your own filters →

Recent Insider Transactions

Transaction Date Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Jan. 22, 2026 Trieu Vuong CHAIRMAN AND CEO A Series A Convertible Preferred Stock 4426 $0.00 8,491.0000 440,778,404 108.88% 0.00%
Nov. 17, 2025 Trieu Vuong CHAIRMAN AND CEO A Series A Convertible Preferred Stock 4065 $0.00 4,065.0000 440,778,404 9999.99% 0.00%
July 8, 2025 Trieu Vuong CHAIRMAN AND CEO P Common Stock 94736 $0.01 117,041,210.0000 408,292,450 0.08% 0.02%
July 10, 2025 Trieu Vuong CHAIRMAN AND CEO P Common Stock 104000 $0.01 116,946,473.0000 408,292,450 0.09% 0.03%
July 9, 2025 Trieu Vuong CHAIRMAN AND CEO P Common Stock 1 $0.01 116,946,474.0000 408,292,450 0.00% 0.00%
Jan. 31, 2025 Trieu Vuong CHAIRMAN AND CEO P Common Stock 63775 $0.03 116,842,473.0000 0 0.05% 0.00%
Jan. 30, 2025 Trieu Vuong CHAIRMAN AND CEO P Common Stock 100003 $0.03 116,778,698.0000 0 0.09% 0.00%
Jan. 29, 2025 Trieu Vuong CHAIRMAN AND CEO P Common Stock 183066 $0.03 116,678,695.0000 0 0.16% 0.00%
Nov. 22, 2024 Trieu Vuong CHAIRMAN AND CEO P Common Stock 298499 $0.03 116,495,629.0000 0 0.26% 0.00%
Aug. 23, 2024 Trieu Vuong CHAIRMAN AND CEO P Common Stock 500000 $0.02 116,197,130.0000 0 0.43% 0.00%